BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3927322)

  • 1. Effects of TRH, ethanol, and TRH-ethanol combination on activity in rats with altered monoamine content.
    Breese GR; Coyle S; Frye GD; Mueller RA
    Pharmacol Biochem Behav; 1985 Jun; 22(6):1013-8. PubMed ID: 3927322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethanol-induced locomotor stimulation in rats after thyrotropin-releasing hormone.
    Breese GR; Coyle S; Towle AC; Mueller RA; McCown TJ; Frye GD
    J Pharmacol Exp Ther; 1984 Jun; 229(3):731-7. PubMed ID: 6427448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of monoamine neural systems in L-dihydroxyphenylalanine-stimulated activity.
    Hollister AS; Breese GR; Mueller RA
    J Pharmacol Exp Ther; 1979 Jan; 208(1):37-43. PubMed ID: 759613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of adult or neonatal treatment with 6-hydroxydopamine or 5,7-dihydroxytryptamine on locomotor activity, monoamine levels, and response to caffeine.
    Erinoff L; Snodgrass SR
    Pharmacol Biochem Behav; 1986 Apr; 24(4):1039-45. PubMed ID: 3086901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alcohol intake, ethanol-induced narcosis and intoxication in rats following neonatal 6-hydroxydopamine or 5, 7-dihydroxytryptamine treatment.
    Kiianmaa K; Attila LM
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Aug; 308(2):165-70. PubMed ID: 574195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of modification of brain serotonin (5-HT), norepinephrine (NE) and dopamine (DA) on ethanol tolerance.
    Lê AD; Khanna JM; Kalant H; LeBlanc AE
    Psychopharmacology (Berl); 1981; 75(3):231-5. PubMed ID: 6798612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain monoamines and free choice ethanol consumption in rats.
    Richardson JS; Novakovski DM
    Drug Alcohol Depend; 1978 Jul; 3(4):253-64. PubMed ID: 567571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of 6-hydroxydopamine or 5,7-dihydroxy-tryptamine on the development of physical dependence on ethanol.
    Frye GD; Ellis FW
    Drug Alcohol Depend; 1977; 2(5-6):349-59. PubMed ID: 562250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of amygdaloid catecholaminergic mechanism in suppressive effects of desipramine and imipramine on duration of immobility in rats forced to swim.
    Araki H; Kawashima K; Uchiyama Y; Aihara H
    Eur J Pharmacol; 1985 Jul; 113(3):313-8. PubMed ID: 3930265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardio-respiratory actions of substance P, TRH and 5-HT in the nucleus tractus solitarius of rats: evidence for functional interactions of neuropeptides and amine neurotransmitters.
    Carter DA; Lightman SL
    Neuropeptides; 1985 Sep; 6(5):425-36. PubMed ID: 2414685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracortical 5,7-dihydroxytryptamine depletes brain serotonin concentrations without affecting spontaneous activity.
    Black RS; Robinson RG
    Pharmacol Biochem Behav; 1985 Feb; 22(2):327-31. PubMed ID: 3983223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraventricular 5,7-dihydroxytryptamine increases thyrotropin-releasing hormone content in regions of rat brain.
    Manaker S; Engber TM; Knight PB; Winokur A
    J Neurochem; 1985 Oct; 45(4):1315-8. PubMed ID: 3928818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Similar motor effects of 5-HT and TRH in rats following chronic spinal transection and 5.7-dihydroxytryptamine injection.
    Barbeau H; Bédard P
    Neuropharmacology; 1981 May; 20(5):477-81. PubMed ID: 6165921
    [No Abstract]   [Full Text] [Related]  

  • 14. Thyrotropin-releasing hormone: hyperactivity and mesolimbic dopamine system in rats.
    Miyamoto M; Narumi S; Nagai Y; Shima T; Nagawa Y
    Jpn J Pharmacol; 1979 Jun; 29(3):335-47. PubMed ID: 119887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanistic and functional divergence between thyrotropin-releasing hormone and RO 15-4513 interactions with ethanol.
    McCown TJ; Breese GR
    Alcohol Clin Exp Res; 1989 Oct; 13(5):660-3. PubMed ID: 2512820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brainstem localization of a thyrotropin-releasing hormone-induced change in respiratory function.
    McCown TJ; Hedner JA; Towle AC; Breese GR; Mueller RA
    Brain Res; 1986 May; 373(1-2):189-96. PubMed ID: 3087573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amphetamine and LSD as discriminative stimuli: alterations following neonatal monoamine reductions.
    Minnema DJ; Rosecrans JA
    Pharmacol Biochem Behav; 1984 Jan; 20(1):95-101. PubMed ID: 6420809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between TRH and ethanol in the medial septum.
    McCown TJ; Moray LJ; Kizer JS; Breese GR
    Pharmacol Biochem Behav; 1986 May; 24(5):1269-74. PubMed ID: 3088607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of vagal afferents and carbon dioxide in the respiratory response to thyrotropin-releasing hormone.
    Mueller RA; Towle AC; Breese GR
    Regul Pept; 1985 Mar; 10(2-3):157-66. PubMed ID: 3922012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of thyrotropin-releasing hormone and cyclo-histidine-proline on the homeothermic development of neonatal rats.
    Sato T; Kato T; Miyamori C; Kajiwara S; Murata A; Imura E; Sakura N; Hashimoto T
    Acta Endocrinol (Copenh); 1986 Oct; 113(2):181-8. PubMed ID: 3096034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.